SBC Medical Group

SBC

Market cap $470M

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of $9.00, representing significant upside from the Company's closing price of $4.44 on January 6, 2026. The Flash Report highlights SBC's major milestone entry into the United States medical aesthetics market through a strategic minority equity investment and structured collaboration framework with OrangeTwist, a leading U.S.-based MedSpa chain.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatments through a hospitality-driven clinical experience, has announced a strategic alliance and minority investment with SBC Medical Group Holdings Incorporated (Nasdaq: SBC) as part of its accelerated national growth strategy. The collaboration marks a significant milestone for OrangeTwist, enabling new clinical, operational, and technological synergies with a.

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical has entered into a Memorandum of Understanding (MoU) for capital investment and strategic alliance with OrangeTwist.

TOKYO--(BUSINESS WIRE)-- #Healthcare--The final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937).

New York, New York--(Newsfile Corp. - December 1, 2025) - Emerging Growth Research today announced the release of its Q3:25 quarterly update on SBC Medical Group Holdings, Inc. (NASDAQ: SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing significant upside from the Company's recent closing price of $3.57 on November 28, 2025. The quarterly update highlights SBC's sequential stabilization in revenue and operating profit during Q3:25, strong cash position, and the Company's positioning for renewed growth beginning in early 2026 as it works through near-term competitive pressures.

IRVINE, Calif.--(BUSINESS WIRE)-- #Medical--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriate.

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Financial results for Q3 FY2025 and the year-to-date period (nine months ended September 30, 2025).

TOKYO--(BUSINESS WIRE)-- #Healthcare--November 13, 2025, SBC resolved to acquire shares of Waqoo, Inc. (Code: 4937), a Tokyo Stock Exchange Growth Market company, through a tender offer.

IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens. Earnings call on Monday, November 17, 2025.

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid dermatology model that integrates insurance-covered general dermatology and private-pay aesthetic treatments, advancing SBC's multi.